Oncologie

Prospective randomized study comparing Mitoxantrone and Vinorelbine with Fluorouracil, Epirubicin or Adriamycin and Cyclophosphamide in patients with Metastatic Breast Cancer

Proceedings of the American Society of Clinical Oncology 1997 Namer M, Soler-Michel P, Mefti F, Chinet-Charrot P, de Gislain C, Pouillart P, Delozier T, Luporsi E, Schraub S, Etienne P-L, Eymard J-C.

Vous souhaitez échanger
avec nos équipes

Contactez-nous

D’autres articles qui pourraient
vous intéresser

Risk Factors TFR CP-CML
Success stories - Oncologie - Facultatif

Identification of Individual Risk Factors for Treatment Free Remission (TFR) Failure in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients

Long-Term TKI Treatment Patterns
Success stories - Oncologie - Facultatif

Tyrosine Kinase Inhibitor (TKI) Treatment Patterns in 5,261 Chronic Phase (CP) Chronic Myeloid Leukemia (CML) Patients in “Real-Life”

Use of Digital Health Technology to Enable Drug Development
Oncologie

Use of Digital Health Technology to Enable Drug Development